A detailed history of Meadow Brook Investment Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Meadow Brook Investment Advisors LLC holds 2,263 shares of ABT stock, worth $258,502. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,263
Previous 2,240 1.03%
Holding current value
$258,502
Previous $233 Million 10.85%
% of portfolio
0.23%
Previous 0.22%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $2,301 - $2,716
23 Added 1.03%
2,263 $258 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $202,025 - $247,296
2,240 New
2,240 $247 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Meadow Brook Investment Advisors LLC Portfolio

Follow Meadow Brook Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meadow Brook Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Meadow Brook Investment Advisors LLC with notifications on news.